RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 
US Urges States and Businesses to Strengthen Taiwan Ties Amid China Pressure 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Republican Lawmaker Introduces AI Incident Reporting Bill to Strengthen U.S. AI Safety 
Iran Attack in Strait of Hormuz Pushes Oil Prices Higher 
US Seeks Gulf Support for Iran Peace Deal Amid Regional Tensions 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies 
Marco Rubio Reassures Gulf Allies Over U.S.-Iran Peace Deal 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Trump Administration Rejects Claims of Rift Between JD Vance and Marco Rubio on Iran Policy 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.
